Iqvia Holdings (IQV) Common Equity (2011 - 2026)
Iqvia Holdings' (IQV) quarterly Common Equity came in at $6.3 billion in Q2 2026, up 8.9% year-over-year from $5.8 billion in Q2 2025, and down 0.76% quarter-over-quarter from $6.3 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Common Equity (2011 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Common Equity across 16 years of filings, most recently posting $6.3 billion for Q2 2026.
- In Q2 2026, Common Equity rose 8.9% year-over-year to $6.3 billion; the TTM figure through Jun 2026 stood at $6.3 billion (up 8.9% YoY), while the FY2025 annual figure was $6.6 billion, up 9.28% from the prior year.
- Common Equity came in at $6.3 billion for Q2 2026 at Iqvia Holdings, down from $6.3 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $7.0 billion in Q3 2024 to a low of $5.4 billion in Q2 2022.
- Average Common Equity over 5 years is $6.1 billion, with a median of $6.0 billion recorded in 2024.
- Year-over-year, Common Equity increased 20.02% in 2024 and decreased 13.82% in 2025.
- Over 5 years, Common Equity stood at $5.8 billion in 2022, then increased by 6.02% to $6.1 billion in 2023, then decreased by 0.74% to $6.1 billion in 2024, then rose by 9.28% to $6.6 billion in 2025, then dropped by 4.96% to $6.3 billion in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $6.3 billion in Q2 2026, $6.3 billion in Q1 2026, and $6.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 6.30 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 433.86 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 9.38 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 2.85 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 524.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 773.64 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 420.28 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 4.46 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 4.96 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.30 Bn |
| Mar 31, 2026 | 6.35 Bn |
| Dec 31, 2025 | 6.63 Bn |
| Sep 30, 2025 | 6.29 Bn |
| Jun 30, 2025 | 5.79 Bn |
| Mar 31, 2025 | 5.99 Bn |
| Dec 31, 2024 | 6.07 Bn |
| Sep 30, 2024 | 6.97 Bn |
| Jun 30, 2024 | 6.71 Bn |
| Mar 31, 2024 | 6.34 Bn |
| Dec 31, 2023 | 6.11 Bn |
| Sep 30, 2023 | 5.81 Bn |
| Jun 30, 2023 | 5.75 Bn |
| Mar 31, 2023 | 5.93 Bn |
| Dec 31, 2022 | 5.77 Bn |
| Sep 30, 2022 | 5.93 Bn |
| Jun 30, 2022 | 5.35 Bn |
| Mar 31, 2022 | 5.92 Bn |
| Dec 31, 2021 | 6.04 Bn |
| Sep 30, 2021 | 5.83 Bn |